Kai Schiemann,Wolfgang Staehle,Michael Busch,Dirk Wienke,Oliver Poeschke,Christa Burger
申请号：
US14344267
公开号：
US09527850B2
申请日:
2012.09.07
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention provides novel substituted benzyl piperidine compounds according to Formula (I) as lysophosphatidic acid (LPA) receptor antagonists, their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.
